Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Oct 14, 2022; 28(38): 5602-5613
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5602
Table 4 Univariate and multivariate analyses of the factors associated with 30-d mortality
Variables
Univariate analysis
Multivariate analysis
OR (95%CI)
P value
OR (95%CI)
P value
Age≥ 75 yr1.772 (0.393-7.991)0.456
< 75 yr
Reference
Common bile duct stonesYes0.254 (0.056-1.146)0.075
No
Reference
Malignant biliary obstructionYes6.817 (1.494-31.109)0.0137.718 (0.664-89.660)0.102
No
Reference
Fever, BT ≥ 39 °CYes1.045 (0.124-8.777)0.968
No
Reference
Abnormal WBC countYes1.789 (0.345-9.289)0.489
No
Reference
Hyperbilirubinemia, ≥ 5 mg/dLYes1.382 (0.307-6.228)0.673
No
Reference
Hepatic dysfunction, PT-INR > 1.5Yes8.896 (1.645-48.119)0.0112.257 (0.275-18.553)0.449
No
Reference
Hematological dysfunction, PLT < 100 × 103/µLYes4.885 (0.919-25.649)0.063
No
Reference
Renal dysfunction, Cr > 2.0 mg/dLYes4.548 (0.862-23.998)0.074
No
Reference
Respiratory dysfunction, PaO2/FiO2 ratio > 300Yes10.517 (2.284-48.431)0.0031.644 (0.172-15.676)0.666
No
Reference
Neurological dysfunction, conscious disturbanceYes15.094 (3.241-70.298)0.0012.773 (0.380-20.238)0.315
No
Reference
Cardiovascular dysfunction1Yes18.750 (3.990-88.112)< 0.00117.756 (0.994-317.241)0.050
No
Reference
Severity of ACGrade III18.732 (2.239-156.728)0.0073.603 (0.274-47.356)0.329
Grade II + I
Reference
ICU admissionYes7.326 (1.373-39.101)0.022.463 (0.204-29.703)0.478
No
Reference
Time to ERCPEvery 1-d delay1.950 (1.252-3.038)0.0032.081 (1.154-3.753)0.015